Tofacitinib Citrate for the Treatment of Vitiligo
Brittany G. Craiglow(Yale University), Brett King(Yale University)
Cited by 255
Related Papers
Awareness and Ever-Use of Electronic Cigarettes Among U.S. Adults, 2010-2011
|Nicotine & Tobacco Research|2013|397
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trials
|British Journal of Dermatology|2020|377
Crystal Structure and Photodynamic Behavior of the Blue Emission Variant Y66H/Y145F of Green Fluorescent Protein
|Biochemistry|1997|164
Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata
|Journal of the American Academy of Dermatology|2022|80
Development of the alopecia areata scale for clinical use: Results of an academic–industry collaborative effort
|Journal of the American Academy of Dermatology|2021|79